Previous 10 | Next 10 |
This article series provides a weekly summary of dividend changes. A summary table provides relevant data and key statistics of dividend increases. We provide a snapshot analysis of one of the stocks worth considering, whether to buy or to add to your watchlist. 9 dividend inc...
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion, Contender, An...
Cyanotech is getting new wholesale orders for bulk microalgae production in Hawaii. Wall Street has not recognized the uptick in customer demand, or the possibility for stronger growth starting in 2022. The stock is incredibly undervalued and underfollowed today. Technical mom...
Medifast (NYSE:MED) declares $1.64/share quarterly dividend, 15.5% increase from prior dividend of $1.42. Forward yield 3.63% Payable May 9; for shareholders of record March 29; ex-div March 28. See MED Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Med...
By the end of 2021, Medifast's revenue grew by 63.2%, and the number of coaches grew by 35.3% year-over-year to 59.8 thousand. A new distribution center in Fort Worth, Texas, will help the company further increase its capacity to support over $2.5 billion in revenue by the end of 2022...
Dividends are a powerful tool that investors should employ to achieve a balance of total return and low volatility. Retirees who rely on dividends for income should approach dividend payers differently. My ideal dividend payer accomplishes four goals: maximize total return, delive...
Medifast, Inc. (MED) Q4 2021 Earnings Conference Call February 23, 2022 4:30 PM ET Company Participants Reed Anderson – Investor Relations-ICR, Inc. Dan Chard – Chairman and Chief Executive Officer Jim Maloney – Chief Financial Officer Conference Call Participants Steph W...
Medifast press release (NYSE:MED): Q4 GAAP EPS of $2.91 beats by $0.26. Revenue of $377.8M (+42.6% Y/Y) beats by $2.01M. Outlook: The company expects full-year 2022 revenue to be in the range of $1.72 billion to $1.79 billion and full-year 2022 diluted EPS to be in the range of $14.50 to $16....
Medifast, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results PR Newswire BALTIMORE , Feb. 23, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTA VIA...
Medifast Named One of America's Best Mid-Sized Companies by Forbes Company ranks within top 25 percent on Forbes' 2022 list PR Newswire BALTIMORE , Feb. 22, 2022 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastest-growing he...
News, Short Squeeze, Breakout and More Instantly...
Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTA VIA®, will announce financial results for the second quarter ended June 30, 2024 on Monday, August 5, 2024, after market close. The Company will host a conferen...
2024-07-03 02:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...